Congressional Stock Trades & Disclosures
James M. Inhofe is a U.S. Senator, a Republican representing OK. As of January 2021, Bullish Whales has tracked 274 disclosed stock trades across 90 companies, representing $15.6M in disclosed transaction value, each filed publicly under the STOCK Act.
About Inhofe's congressional trading
Inhofe's disclosed activity shows a sell-leaning pattern, with 100 purchases and 174 sales (a buy-to-sell ratio of 0.57). Inhofe has traded GE, MSFT, and BLK most frequently among disclosed positions.
On the Bullish Whales Score, which ranks members of Congress by how worth-following their disclosed buys have been relative to peers, Inhofe rates 94 out of 100, a Elite reading. The score weights a member's realized track record (80%) and conviction in repeat positions (20%); it is a descriptive research signal drawn from public filings, not investment advice.
Inhofe's most recent disclosed trade was a sale of Crispr Therapeutics AG (CRSP) from January 2021. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 CRSPCrispr Therapeutics AG | Sell | $1,001 - $15,000 | 05 JAN 2021 | $160.62 | -67.58% |
| CRSPCrispr Therapeutics AG | Sell | $50,001 - $100,000 | 22 DEC 2020 | $170.08 | -69.38% |
 BLKBlackRock Inc | Sell | $50,001 - $100,000 | 15 DEC 2020 | $615.87 | +60.89% |
| BLKBlackRock Inc | Sell | $50,001 - $100,000 | 15 DEC 2020 | $615.87 | +60.89% |
 AAPLApple Inc | Sell | $15,001 - $50,000 | 15 JUL 2020 | $94.62 | +227.90% |
| AAPLApple Inc | Sell | $15,001 - $50,000 | 15 JUL 2020 | $94.62 | +227.90% |
 AMZNAmazon.com Inc | Sell | $15,001 - $50,000 | 15 JUL 2020 | $150.44 | +66.19% |
| AMZNAmazon.com Inc | Sell | $15,001 - $50,000 | 15 JUL 2020 | $150.44 | +66.19% |
 BAMBrookfield Asset Management Ltd. | Sell | $1,001 - $15,000 | 29 JUN 2020 | N/A | — |
 MSFTMicrosoft Corporation | Sell | $50,001 - $100,000 | 13 APR 2020 | $156.88 | +172.40% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
James M. Inhofe congressional trading FAQ
Can James M. Inhofe legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles James M. Inhofe's disclosures so the public can review them.
Where does Bullish Whales get James M. Inhofe's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track James M. Inhofe's stock trades?
Bullish Whales tracks every stock trade James M. Inhofe discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has James M. Inhofe disclosed?
Bullish Whales has tracked 274 disclosed trades by James M. Inhofe across 90 companies.
Which stocks does James M. Inhofe trade most?
James M. Inhofe's most frequently disclosed positions include GE, MSFT, BLK, CLR, and C. The full list of companies and individual filings is shown on this page.
What was James M. Inhofe's most recent stock trade?
James M. Inhofe most recently sold Crispr Therapeutics AG (CRSP) in January 2021, according to public STOCK Act filings tracked by Bullish Whales.
What is James M. Inhofe's Bullish Whales Score?
James M. Inhofe has a Bullish Whales Score of 94 out of 100 (Elite). The score ranks members by how worth-following their disclosed buys have been, weighting realized track record (80%) and conviction (20%). It is a descriptive research signal, not investment advice.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.